NCT04253470

Brief Summary

The association between serum progesterone (P) levels, measured on the day of ovulation trigger, and the outcome of in vitro fertilization cycles, has been one of the major controversies in the field of ovarian stimulation endocrinology. This is a single-center retrospective cohort study. Study duration period is from January 2012 to December 2016. All fresh embryo transfer (ET) both at cleavage stage and blastocyst stage, performed in Humanitas Fertility Center during the study period, were included.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2016

Completed
2.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 31, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 5, 2020

Completed
Last Updated

February 5, 2020

Status Verified

January 1, 2020

Enrollment Period

5 years

First QC Date

January 31, 2020

Last Update Submit

January 31, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Impact of PE on CPR and LBR

    To evaluate the impact of premature high serum P levels on the outcome of fresh embryo transfer cycles in terms of Clinical Pregnancy Rates (CPR) and Live Birth Rates (LBR).

    January 2012-December 2016

Secondary Outcomes (1)

  • Blastocyst embryo transfers' outcomes in PE

    January 2012-December 2016

Study Arms (2)

cleavage stage embryo

embryo which is on day 2 or 3

Other: embryo transfer

blastocyst embryo

embryo which is on day 5

Other: embryo transfer

Interventions

Step of the assisted reproduction in which embryos are placed into the uterus in order to obtain a pregnancy

blastocyst embryocleavage stage embryo

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All fresh embryo transfers both at cleavage stage (Day 2 and Day3) and blastocyst stage (Day 5), and all thawed embryo transfer, except from the ones deriving from PGTA, performed from January 2012 to December 2016 in Humanitas Fertility Center were included.

You may qualify if:

  • All fresh embryo transfers both at cleavage stage (Day 2 and Day3) and blastocyst stage (Day 5)
  • Thawed embryo transfer deriving from supernumerary embryos cycles, by P increase, by OHSS, by other reasons (i.e inadequate endometrium, medical complications, etc)

You may not qualify if:

  • thawed embryo transfers deriving from PGTA.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Paolo Emanuele Levi Setti

Rozzano, MI, 20089, Italy

Location

Related Publications (1)

  • De Cesare R, Morenghi E, Cirillo F, Ronchetti C, Canevisio V, Persico P, Baggiani A, Sandri MT, Levi-Setti PE. The Role of hCG Triggering Progesterone Levels: A Real-World Retrospective Cohort Study of More Than 8000 IVF/ICSI Cycles. Front Endocrinol (Lausanne). 2020 Sep 23;11:547684. doi: 10.3389/fendo.2020.547684. eCollection 2020.

MeSH Terms

Conditions

Infertility, Female

Interventions

Embryo Transfer

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesInfertility

Intervention Hierarchy (Ancestors)

Reproductive Techniques, AssistedReproductive TechniquesTherapeuticsInvestigative Techniques

Study Officials

  • Raffaella De Cesare

    Humanitas clinical and research hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2020

First Posted

February 5, 2020

Study Start

January 1, 2012

Primary Completion

December 31, 2016

Study Completion

October 1, 2019

Last Updated

February 5, 2020

Record last verified: 2020-01

Data Sharing

IPD Sharing
Will not share

Locations